Drug Database
Back to search

Poland· PL-100322864

Ebilfumin

A oseltamivir product containing oseltamivirum, registered in Poland by Actavis Group PTC ehf.. The same ATC class is registered in 16 of our 19 countries.

ATC J05AH02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedEbilfuminATCJ05AH02REGISTER NO.PL-100322864PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about oseltamivirumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Oseltamivir is registered in 16 of 19 countries.

Countries holding a registration under ATC J05AH02 (oseltamivir), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 10 of them publish a price we can compare per daily dose
Search oseltamivir products by name

Oseltamivir · ATC J05AH02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Oseltamivirum
Manufacturer
Actavis Group PTC ehf.
Country
Poland (PL)
ATC code
J05AH02
ATC class
Oseltamivir
Defined daily dose
0.15 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909991185671
  • gtin
    05903792743801
  • gtin
    05909991595050
  • gtin
    5901878601199

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

93 interactions on record for oseltamivir.

Graded by severity as the source publishes them — 4 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check oseltamivir against other medicinesHow interaction checks work

Oseltamivir · interactions on record

93 records

  • 4 moderate
  • 1 minor
  • 88 info

Most severe, free to view

  • MethotrexateL01BA01moderate
  • PemetrexedL01BA04moderate
  • MethotrexateL04AX03moderate
  • MethotrexatM01CX01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Oseltamivir in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oseltamivir products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Bulgaria · Бетафлу
  • Germany · Oseltamivir Hec Pharm, Oseltamivir Stada
  • Estonia · Segosana
  • Spain · Oseltamivir Accord
  • France · Oseltamivir Zentiva
  • United Kingdom (Northern Ireland) · Oseltamivir, Oseltamivir Accord-Uk
  • Hungary · Segosana
  • Iceland · Ebilfumin, Tamiflu
  • Liechtenstein · Ebilfumin, Tamiflu
  • Lithuania · Segosana
  • Latvia · Segosana
  • Netherlands · Oseltamivir Zentiva, Segosana
  • Norway · Ebilfumin, Tamiflu
  • Romania · Oseltamivir Accord, Oseltamivir Laropharm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a7136f22-8fea-471f-b523-3b2e46b8a108
GET /v1/drugs/a7136f22-8fea-471f-b523-3b2e46b8a108?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "75 mg",
  "packaging": "05909991185671 ¦ Rp ¦ EU/1/14/915/005 ¦ 102913\n10 kaps. w blistrze\nRp ¦ EU/1/14/915/006 ¦ 102914\n10 kaps. w pojemniku\n05903792743801 ¦ Rp ¦ EU/1/14/915/005 ¦ InPharm Sp. z o.o. ¦ 163104\n10 kaps. w blistrze\n05909991595050 ¦ Rp ¦ EU/1/14/915/005 ¦ Medezin Sp. z o.o. ¦ 165933\n10 kaps. \n5901878601199 ¦ Rp ¦ EU/1/14/915/005 ¦ Delfarma Sp. z o.o. ¦ 168107\n1 blister 10 kaps.",
  "substance": "Oseltamivirum 75 mg",
  "common_name": "Oseltamivirum",
  "pl_product_id": "100322864",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about oseltamivir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console